GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adlai Nortye Ltd (NAS:ANL) » Definitions » Interest Expense

ANL (Adlai Nortye) Interest Expense : $-0.24 Mil (TTM As of Jun. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Adlai Nortye Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Adlai Nortye's interest expense for the three months ended in Jun. 2024 was $ 0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jun. 2024 was $-0.24 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Adlai Nortye's Operating Income for the three months ended in Jun. 2024 was $ 0.00 Mil. Adlai Nortye's Interest Expense for the three months ended in Jun. 2024 was $ 0.00 Mil. Adlai Nortye has no long-term debt (1). The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

(1) Note: An indication of "no long-term debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

Adlai Nortye Interest Expense Historical Data

The historical data trend for Adlai Nortye's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adlai Nortye Interest Expense Chart

Adlai Nortye Annual Data
Trend Dec21 Dec22 Dec23
Interest Expense
-0.58 -0.43 -0.79

Adlai Nortye Quarterly Data
Dec21 Mar22 Jun22 Dec22 Mar23 Jun23 Dec23 Jun24
Interest Expense Get a 7-Day Free Trial - -0.08 -0.16 - -

Adlai Nortye Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.24 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Adlai Nortye  (NAS:ANL) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Adlai Nortye's Interest Expense for the three months ended in Jun. 2024 was $0.00 Mil. Its Operating Income for the three months ended in Jun. 2024 was $0.00 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Jun. 2024 was $0.00 Mil.

Adlai Nortye's Interest Coverage for the quarter that ended in Jun. 2024 is calculated as

Adlai Nortye had no long-term debt (1).

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Adlai Nortye Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adlai Nortye Ltd (NAS:ANL) » Definitions » Interest Expense
Comparable Companies
MGTX KALV JANX AVTE ABUS VYGR BLUE AGEN FUSN CRBU OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N2U0:Germany
Address
685 US Highway 1, New Jersey Biotechnology Development Center, 2nd floor, North Brunswick, NJ, USA, 08902
Website
https://www.adlainortye.com
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.